These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23083575)

  • 21. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion weighted imaging: a long way to clinical routine.
    Woodhams R; Ozaki M; Hata H; Inoue Y
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S185-7. PubMed ID: 23083584
    [No Abstract]   [Full Text] [Related]  

  • 23. Do we really need new contrast agents for MR-mammography?
    Rachetta E; Spinelli R; Martincich L
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S127-8. PubMed ID: 23083558
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast MR for intraductal masses.
    Harms SE; Harms DE; Pope K; Grear D; Smith-Foley S; Johnson K
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S59-60. PubMed ID: 23083603
    [No Abstract]   [Full Text] [Related]  

  • 25. Supine breast MRI and assessment of future clinical applications.
    Siegler P; Ebrahimi M; Holloway CM; Thevathasan G; Plewes DB; Martel A
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S153-5. PubMed ID: 23083571
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffusion weighted imaging (DWI) of the breast: ready for clinical practice?
    Lehman CD
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S80-1. PubMed ID: 23083614
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-Enhanced Digital Mammography.
    Monreal S
    Radiol Technol; 2018 May; 89(5):518-520. PubMed ID: 29793915
    [No Abstract]   [Full Text] [Related]  

  • 29. CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer.
    Schmitt B; Trattnig S; Schlemmer HP
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S144-6. PubMed ID: 23083567
    [No Abstract]   [Full Text] [Related]  

  • 30. Wish list for future features of breast MRI computer aided evaluation.
    Kelcz F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S78-9. PubMed ID: 23083613
    [No Abstract]   [Full Text] [Related]  

  • 31. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-look ultrasound: only for biopsy or more?
    Leung JW
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S87-9. PubMed ID: 23083617
    [No Abstract]   [Full Text] [Related]  

  • 33. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance.
    Hobbs MM; Taylor DB; Buzynski S; Peake RE
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-Enhanced Mammography Implementation, Performance, and Use for Supplemental Breast Cancer Screening.
    Covington MF
    Radiol Clin North Am; 2021 Jan; 59(1):113-128. PubMed ID: 33222993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.
    Brown J; Buckley D; Coulthard A; Dixon AK; Dixon JM; Easton DF; Eeles RA; Evans DG; Gilbert FG; Graves M; Hayes C; Jenkins JP; Jones AP; Keevil SF; Leach MO; Liney GP; Moss SM; Padhani AR; Parker GJ; Pointon LJ; Ponder BA; Redpath TW; Sloane JP; Turnbull LW; Walker LG; Warren RM
    Magn Reson Imaging; 2000 Sep; 18(7):765-76. PubMed ID: 11027869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What to do with B3 lesions at needle biopsy.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S90-2. PubMed ID: 23083618
    [No Abstract]   [Full Text] [Related]  

  • 38. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
    Fallenberg EM; Dromain C; Diekmann F; Renz DM; Amer H; Ingold-Heppner B; Neumann AU; Winzer KJ; Bick U; Hamm B; Engelken F
    Breast Cancer Res Treat; 2014 Jul; 146(2):371-81. PubMed ID: 24986697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer-aided diagnosis complements full-field digital mammography.
    Nishikawa RM
    Diagn Imaging (San Franc); 1999 Sep; 21(9):47-51, 75. PubMed ID: 10623317
    [No Abstract]   [Full Text] [Related]  

  • 40. Computed-aided diagnosis (CAD) in the detection of breast cancer.
    Dromain C; Boyer B; Ferré R; Canale S; Delaloge S; Balleyguier C
    Eur J Radiol; 2013 Mar; 82(3):417-23. PubMed ID: 22939365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.